scorecardresearch
Wednesday, August 27, 2025
TopicOxford University

Topic: Oxford University

AstraZeneca-Oxford Covid vaccine produces strong immune response in older adults

The Astra-Oxford vaccine candidate is one of several front-runners in the race for protection against the virus.

AstraZeneca resumes Covid-19 vaccine trial in Japan, US still on hold

The phase 1 and 2 trials resumed after the Japanese regulator gave the go-ahead. Trials in the UK, Brazil, South Africa and India had already restarted in recent weeks.

RECOVERY trial to test REGN-COV2, first specifically designed antibody cocktail for Covid

The RECOVERY trial, the world's largest trial, is currently looking for therapeutic options against Covid.

Still aiming for Oxford Covid vaccine by end of this year, AstraZeneca CEO says

AstraZeneca CEO Pascal Soriot sought to reassure investors after the Oxford vaccine trial was halted due to a person in the UK falling sick, triggering a review of safety data.

Delay of AstraZeneca’s Covid vaccine could be painful but it’s responsible

The AstraZeneca Plc paused the trial of its leading candidate, developed with Oxford University, to study a volunteer's illness. This pause shows the system is working as it should.

Oxford’s new Covid vaccine begins human trials in partnership with Serum Institute of India

Serum Institute of India, the world’s largest vaccine manufacturer, will run trials of the shot developed by SpyBiotech that uses a patented superglue tech to induce an immune response.

Oxford Covid vaccine given to 2 volunteers as Serum Institute begins human trials in India

The Phase 2 trials began in Pune's Bharati Vidyapeeth Medical College and Hospital. A total of 25 volunteers will be enrolled at the hospital.

Oxford vaccine human trial in India a step closer as panel clears Serum Institute protocol 

The protocol will now be moved to DCGI V.G. Somani, who is likely to take a ‘decision by the end of the week’ given the urgency of the Covid challenge.

SII proposes 1,600 subjects in 20 Indian cities for Oxford vaccine trials, govt to decide today

India’s apex clinical trial regulation body will meet urgently to reconsider Serum Institute of India’s proposal after it revised its plan for starting Oxford vaccine's human trials in India.

Two Asian pharma companies hold key to Oxford vaccine, China woos ASEAN & other Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

On Camera

Severe Hyderabad internet outages make it an IT hub without the IT part

Many offices in Telangana have asked their employees to work from home because of heavy rainfall, but it has become impossible due to the internet outages.

‘Not just Russian oil, India tapped us along on trade deal,’ says US treasury secy Scott Bessent

New Delhi: The US is not worried about the rupee “becoming a reserve currency” given that it is at an all-time low versus the...

CDS on differences on theaterisation—views welcome, final call to be in nation’s best interests

The Navy has always been on board with the theaterisation plan, but the Air Force feels splitting up air assets into several theatre commands is futile & will tie up critical systems.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.